These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9260059)

  • 1. Hematologic malignancies.
    Curr Opin Hematol; 1997 Jul; 4(4):B129-73. PubMed ID: 9260059
    [No Abstract]   [Full Text] [Related]  

  • 2. Managing oral mucositis in patients with hematologic malignancies.
    J Support Oncol; 2006 Feb; 4(2):79. PubMed ID: 16499126
    [No Abstract]   [Full Text] [Related]  

  • 3. Mucocutaneous paraneoplastic syndromes in hematologic malignancies.
    Zappasodi P; Forno C; Corso A; Lazzarino M
    Int J Dermatol; 2006 Jan; 45(1):14-22. PubMed ID: 16426369
    [No Abstract]   [Full Text] [Related]  

  • 4. Allogeneic peripheral blood stem cell transplantation in children with hematologic malignancies. AIEOP-BMT Group (Italian Association for Pediatric Hematology and Oncology-Bone Marrow Transplant Group).
    Miniero R; Busca A; Pession A; Rondelli R; Uderzo C; Ripaldi M; Locatelli F
    Haematologica; 1999 Jul; 84(7):657-60. PubMed ID: 10406913
    [No Abstract]   [Full Text] [Related]  

  • 5. Quality of life and treatment value in the management of hematologic malignancies.
    Cella D; Webster KA
    Semin Oncol; 1999 Oct; 26(5 Suppl 14):34-42. PubMed ID: 10561016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Green tea consumption and hematologic malignancies in Japan: the Ohsaki study.
    Naganuma T; Kuriyama S; Kakizaki M; Sone T; Nakaya N; Ohmori-Matsuda K; Hozawa A; Nishino Y; Tsuji I
    Am J Epidemiol; 2009 Sep; 170(6):730-8. PubMed ID: 19640889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A protocol for the evaluation and treatment of oral mucositis in patients with hematological malignancies.
    Puyalt Casado M; Jiménez Martinez C; Chimenos Küstner E; López López J; Juliá A
    Med Oral; 2003; 8(1):10-8. PubMed ID: 12556718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Home care management of patients affected by hematologic malignancies: a review.
    Niscola P; de Fabritiis P; Cartoni C; Romani C; Sorrentino F; Dentamaro T; Piccioni D; Scaramucci L; Giovannini M; Amadori S; Mandelli F
    Haematologica; 2006 Nov; 91(11):1523-9. PubMed ID: 17082010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiogenesis in hematologic malignancies.
    Moehler TM; Neben K; Ho AD; Goldschmidt H
    Ann Hematol; 2001 Dec; 80(12):695-705. PubMed ID: 11797109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hematologic malignancies/pediatric malignancies].
    Usui N
    Gan To Kagaku Ryoho; 2009 May; 36(5):742-3. PubMed ID: 19496282
    [No Abstract]   [Full Text] [Related]  

  • 11. [Second cancers in hematologic malignancies (epidemiologic observations from a 20-year period)].
    Jakó J; Szerafin L; Nagy P
    Orv Hetil; 2005 Mar; 146(10):461-9. PubMed ID: 15835344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and pathogenesis of thrombosis in hematologic malignancies.
    Kwaan HC; Vicuna B
    Semin Thromb Hemost; 2007 Jun; 33(4):303-12. PubMed ID: 17525887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of hematologic malignancies in agriculture.
    Mazza JJ
    J Agromedicine; 2006; 11(2):5-7. PubMed ID: 17135136
    [No Abstract]   [Full Text] [Related]  

  • 14. Motor disability in malignant hematology: an epidemiological study on Italian hospitalized patients.
    Tendas A; Niscola P; Cinque R; Cupelli L; Giovannini M; Ales M; Dentamaro T; Scaramucci L; de Fabritiis P
    Leuk Res; 2010 Feb; 34(2):e66. PubMed ID: 19717190
    [No Abstract]   [Full Text] [Related]  

  • 15. Interleukin-2 in the treatment of hematologic malignancies.
    Fefer A
    Cancer J Sci Am; 2000 Feb; 6 Suppl 1():S31-2. PubMed ID: 10685655
    [No Abstract]   [Full Text] [Related]  

  • 16. Newly diagnosed cases of hematologic malignancies in Sardinia in the early 2000: an estimation of their number, age and geographic distribution on the basis of a previous epidemiologic survey.
    Broccia G; Gabbas A; Longinotti M
    Haematologica; 2005 Mar; 90(3):429-30. PubMed ID: 15749689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Palliative care for patients with hematologic malignancies in Morocco: a real challenge.
    Tazi I
    J Palliat Med; 2011 Mar; 14(3):270. PubMed ID: 21361832
    [No Abstract]   [Full Text] [Related]  

  • 18. Sex-specific patterns and trends in the incidence of hematologic malignancies in 0-24 year olds from Northern England, 1968-2005.
    Magnanti BL; Dorak MT; Parker L; Craft AW; James PW; McNally RJ
    Haematologica; 2008 Sep; 93(9):1438-40. PubMed ID: 18603551
    [No Abstract]   [Full Text] [Related]  

  • 19. Venous thromboembolism in the hematologic malignancies.
    Falanga A; Marchetti M
    J Clin Oncol; 2009 Oct; 27(29):4848-57. PubMed ID: 19752334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA targeted therapeutics for hematologic malignancies.
    Gewirtz AM
    Blood Cells Mol Dis; 2007; 38(2):117-9. PubMed ID: 17215146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.